Glooko announced that it entered into a global partnership with Hedia to integrate its technology into Glooko’s diabetes management platforms. The companies aim to provide an interoperable solution that brings together connected care, remote patient monitoring and digital therapeutics. This combination could enhance access for those with type 1 and type 2 diabetes requiring bolus […]
Diabetes
Glytec unveils enhanced GlucoMetrics insulin management software
Glytec announced today that it unveiled the next evolution of GlucoMetrics to provide new insights into glycemic outcomes. The enhanced GlucoMetrics platform offers new analytics, dashboards and data visualizations for health systems and hospitals. Offering this enhanced visibility into glycemic outcomes helps hospitals as they prepare for new Centers for Medicare and Medicaid Services (CMS) […]
Novo Nordisk, Aspect Biosystems ink $75M deal for diabetes treatments
Aspect Biosystems and Novo Nordisk today announced a collaboration, development and license agreement around diabetes and obesity treatments. The agreement focuses on bioprinted tissue therapeutics designed to replace, repair or supplement the body’s biological functions. Novo Nordisk and Aspect aim to deliver a new class of disease-modifying treatments for diabetes and obesity. It leverages Aspect’s […]
Abbott FreeStyle Libre reader warning affects more than 4 million devices
The FDA today issued a notice classifying a recall of Abbott (NYSE:ABT) FreeStyle Libre readers as Class I, the most serious kind. Earlier this week, Abbott initiated a voluntary medical device correction to emphasize instructions for FreeStyle Libre continuous glucose monitor (CGM) readers. The company said it received a limited number of global reports (0.0017%) from […]
Senseonics announces equity grants to employees under inducement plan
Senseonics (NYSE:SENS) announced today that it made equity grants to new employees under its 2019 inducement plan. The Germantown, Maryland-based long-term continuous glucose monitor (CGM) maker made these grants in accordance with NYSE requirements. On April 4, 2023, Senseonics granted 13 new non-executive employees non-qualified stock options. These options enable the employees to purchase an aggregate […]
Abbott warns on some FreeStyle Libre readers due to battery issues
Abbott (NYSE:ABT) initiated a voluntary medical device correction to emphasize instructions for FreeStyle Libre continuous glucose monitor (CGM) readers. The instructions cover the FreeStyle Libre, Libre 14-day and Libre 2 readers in the U.S. Abbott received a limited number of global reports (0.0017%) from users over several years saying their reader’s lithium-ion battery swelled or […]
Bigfoot Biomedical acquires insulin titration algorithm developed at McGill University
Bigfoot Biomedical announced today that it acquired a reinforcement learning algorithm for insulin titration from McGill University. Developers at McGill designed the algorithm to observe how well people with insulin-requiring diabetes respond to a particular dose. It provides a recommended adjustment based on the body’s response. Milpitas, California-based Bigfoot said the developers built the algorithm […]
Better Therapeutics hopes FDA nod for diabetes digital therapeutic comes in 2023
Better Therapeutics (Nasdaq:BTTX) shares ticked up on fourth-quarter results and projections for its flagship product in 2023. The company’s quarterly results come on the heels of a 35% headcount reduction. Better Therapeutics said the headcount cut comes as part of a cost reduction initiative. It aims to improve its cash runway and “focus on the long-term success […]
This implantable fuel cell generates electricity from glucose
A team of researchers developed an implantable fuel cell that uses excess glucose from tissue to generate electrical energy. By combining the fuel cell with artificial data cells, the team produced insulin with the touch of a button. This effectively lowered blood glucose levels like the natural process in the pancreas. Given that current treatments […]
11 diabetes tech startups you need to know
The diabetes technology space is one that’s always innovating. From continuous glucose monitoring to insulin pumps and the artificial pancreas, we’ve seen a lot. Companies are looking for all kinds of ways to make their mark in the world of diabetes. Newer offerings include digital health, software, coaching and more. For companies still in their […]